lobbying_activities: 3001232

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3001232	f376ed09-b536-4cbe-968c-8642a1596970	Q2	HOLLAND & KNIGHT LLP	18466	VIATRIS INC	2023	second_quarter	PHA	Increasing Transparency in Generic Drug Applications Act, (S. 775), Part D Formulary Design; Supply Chain Issues, E-labeling; Inflation Reduction Act Implementation, Improving Generic Drug Access, PEPFAR.	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2023-07-12T07:45:28-04:00